Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $18,604 | 1,079 | 99.5% |
| Education | $96.69 | 9 | 0.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $2,605 | 157 | $0 (2024) |
| ABBVIE INC. | $2,590 | 114 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,411 | 80 | $0 (2024) |
| Celgene Corporation | $1,047 | 51 | $0 (2019) |
| Lilly USA, LLC | $1,016 | 75 | $0 (2024) |
| PFIZER INC. | $964.90 | 79 | $0 (2022) |
| Janssen Biotech, Inc. | $911.24 | 46 | $0 (2024) |
| GlaxoSmithKline, LLC. | $815.10 | 43 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $713.34 | 46 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $588.01 | 36 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,498 | 106 | ABBVIE INC. ($418.54) |
| 2023 | $3,176 | 148 | AbbVie Inc. ($1,050) |
| 2022 | $2,144 | 118 | ABBVIE INC. ($317.33) |
| 2021 | $1,903 | 114 | Amgen Inc. ($391.35) |
| 2020 | $1,801 | 117 | Amgen Inc. ($375.23) |
| 2019 | $2,614 | 169 | Amgen Inc. ($537.55) |
| 2018 | $2,287 | 152 | Celgene Corporation ($337.61) |
| 2017 | $2,277 | 164 | Celgene Corporation ($497.87) |
All Payment Transactions
1,088 individual payment records from CMS Open Payments — Page 1 of 44
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Amgen Inc. | Enbrel (Biological), Otezla | Food and Beverage | In-kind items and services | $18.67 | General |
| Category: Inflammation | ||||||
| 12/12/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $13.63 | General |
| Category: Oncology | ||||||
| 12/10/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $19.91 | General |
| Category: Inflammation/Rare Disease | ||||||
| 12/09/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $13.71 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/05/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $13.72 | General |
| Category: Endocrinology | ||||||
| 12/03/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $17.65 | General |
| Category: Dermatology | ||||||
| 11/21/2024 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: IMMUNOLOGY | ||||||
| 11/19/2024 | Organon Llc | HADLIMA (Drug), RENFLEXIS | Food and Beverage | In-kind items and services | $20.42 | General |
| Category: ADALIMUMAB-BWWD | ||||||
| 11/19/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $20.39 | General |
| Category: Diabetes | ||||||
| 11/15/2024 | GlaxoSmithKline, LLC. | BENLYSTA (Biological), NUCALA | Food and Beverage | In-kind items and services | $13.80 | General |
| Category: IMMUNOLOGY | ||||||
| 11/07/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $77.93 | General |
| Category: Immunology | ||||||
| 11/06/2024 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Food and Beverage | In-kind items and services | $15.27 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 11/04/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $17.34 | General |
| Category: IMMUNOLOGY | ||||||
| 10/31/2024 | ANI Pharmaceuticals, Inc. | PURIFIED CORTROPHIN GEL (Drug) | Food and Beverage | In-kind items and services | $184.62 | General |
| Category: Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | ||||||
| 10/29/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $27.60 | General |
| Category: Biological | ||||||
| 10/16/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $23.87 | General |
| Category: Bone Health | ||||||
| 10/16/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $21.08 | General |
| Category: IMMUNOLOGY | ||||||
| 10/15/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.16 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/14/2024 | Amneal Pharmaceuticals LLC | UNITHROID (Drug) | Food and Beverage | In-kind items and services | $14.52 | General |
| Category: ENDOCRINOLOGY | ||||||
| 10/10/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $17.78 | General |
| Category: Inflammation/Rare Disease | ||||||
| 10/08/2024 | Amgen Inc. | Enbrel (Biological), Otezla | Food and Beverage | In-kind items and services | $22.37 | General |
| Category: Inflammation | ||||||
| 10/04/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $18.63 | General |
| Category: Respiratory | ||||||
| 10/01/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $22.80 | General |
| Category: Biological | ||||||
| 09/30/2024 | Lilly USA, LLC | JARDIANCE (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $16.31 | General |
| Category: Diabetes | ||||||
| 09/26/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $16.57 | General |
| Category: Cardio-renal | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 17 | 1,003 | 2,850 | $208,935 | $99,379 |
| 2022 | 24 | 1,195 | 3,912 | $267,695 | $126,344 |
| 2021 | 24 | 1,092 | 2,795 | $205,180 | $98,478 |
| 2020 | 18 | 1,106 | 2,761 | $212,410 | $93,054 |
All Medicare Procedures & Services
83 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 20 | 1,625 | $56,875 | $28,392 | 49.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 186 | 186 | $37,200 | $22,361 | 60.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 162 | 204 | $37,740 | $14,338 | 38.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 129 | 162 | $23,490 | $8,746 | 37.2% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 79 | 82 | $8,200 | $5,796 | 70.7% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 20 | 20 | $8,580 | $5,356 | 62.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 89 | 92 | $3,220 | $2,659 | 82.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 19 | 21 | $5,145 | $2,544 | 49.4% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 17 | 17 | $6,375 | $2,505 | 39.3% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 96 | 171 | $5,985 | $1,628 | 27.2% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 28 | 32 | $3,040 | $1,032 | 33.9% |
| 96401 | Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2023 | 21 | 29 | $3,625 | $1,016 | 28.0% |
| G2012 | Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m servic | Office | 2023 | 70 | 95 | $4,750 | $826.98 | 17.4% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 12 | 12 | $1,140 | $688.95 | 60.4% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 21 | 68 | $2,380 | $645.02 | 27.1% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 18 | 18 | $630.00 | $520.20 | 82.6% |
| 90688 | Influenza vaccine, quadrivalent, 0.5 ml dosage | Office | 2023 | 16 | 16 | $560.00 | $326.97 | 58.4% |
| J0897 | Injection, denosumab, 1 mg | Office | 2022 | 25 | 2,460 | $86,100 | $40,672 | 47.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 198 | 198 | $39,600 | $23,698 | 59.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 196 | 250 | $46,250 | $18,841 | 40.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 135 | 156 | $22,620 | $9,471 | 41.9% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2022 | 21 | 21 | $6,825 | $5,270 | 77.2% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 72 | 72 | $7,200 | $4,798 | 66.6% |
| 99495 | Transitional care management services for problem of moderate complexity | Office | 2022 | 21 | 23 | $8,625 | $3,542 | 41.1% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2022 | 11 | 14 | $6,650 | $2,536 | 38.1% |
About Dr. Phillip Triplett, D.O
Dr. Phillip Triplett, D.O is a Internal Medicine healthcare provider based in Charleston, West Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/05/2006. The National Provider Identifier (NPI) number assigned to this provider is 1083645758.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Phillip Triplett, D.O has received a total of $18,701 in payments from pharmaceutical and medical device companies, with $2,498 received in 2024. These payments were reported across 1,088 transactions from 62 companies. The most common payment nature is "Food and Beverage" ($18,604).
As a Medicare-enrolled provider, Triplett has provided services to 4,396 Medicare beneficiaries, totaling 12,318 services with total Medicare billing of $417,254. Data is available for 4 years (2020–2023), covering 83 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Charleston, WV
- Active Since 07/05/2006
- Last Updated 01/21/2026
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1083645758
Products in Payments
- Enbrel (Biological) $1,201
- RINVOQ (Biological) $1,080
- FARXIGA (Drug) $846.00
- EVENITY (Biological) $605.40
- KRYSTEXXA (Biological) $568.61
- Vascepa (Drug) $499.67
- JARDIANCE (Drug) $479.61
- XELJANZ (Drug) $440.46
- Cimzia (Drug) $439.68
- SIMPONI ARIA (Biological) $422.83
- BENLYSTA (Biological) $421.58
- SKYRIZI (Biological) $417.35
- Otezla (Drug) $405.43
- COSENTYX (Biological) $393.81
- UBRELVY (Drug) $381.03
- ACTHAR (Biological) $304.70
- REMICADE (Biological) $300.05
- Prolia (Biological) $280.13
- TRULICITY (Drug) $270.81
- SHINGRIX (Biological) $266.04
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Charleston
William Chapman, Do, DO
Internal Medicine — Payments: $1.3M
Dr. Ryan Tedford, M.d, M.D
Internal Medicine — Payments: $432,170
Harold Szerlip, Md, MD
Internal Medicine — Payments: $284,278
Dr. Nathan Shores, M.d, M.D
Internal Medicine — Payments: $262,570
Hamza Hashmi, M.d, M.D
Internal Medicine — Payments: $234,146
Dr. Anne Kroman, D.o., Phd, D.O., PHD
Internal Medicine — Payments: $202,518